Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 386 for “"oncolytic"”.

  1. Oncolytic Viruses in Lymphoma

    … is commonly seen in indolent Lymphoma subtypes. Oncolytic virus (OV) therapies are an emerging treatment option for many malignancies and the first OV has recently been approved by the FDA for the treatment of melanoma. The aim of OV therapy is to effectively replicate within the host, …

    whiterose Download file for Oncolytic Viruses in Lymphoma (opens in a new tab)

  2. Improving Direct Oncolytic Effect Of Oncolytic Hsv To Overcome Therapeutic Resistance Of Brain Tumors

    … desperately needed. One promising approach is oncolytic viruses (OVs), which achieve tumor regression by two separate oncolytic effects: 1) direct oncolysis of cancer cells through viral infection, replication, and lysis, and 2) stimulation of an antitumor immune response. Oncolytic herpes …

    uab Repository record for Improving Direct Oncolytic Effect Of Oncolytic Hsv To Overcome Therapeutic Resistance Of Brain Tumors (opens in a new tab)

  3. Mathematical modelling of oncolytic virotherapy

    … is concerned with mathematical modelling of oncolytic virotherapy: the use of genetically modified viruses to selectively spread, replicate and destroy cancerous cells in solid tumours. Traditional spatially-dependent modelling approaches have previously assumed that virus spread is due to …

    oxford Repository record for Mathematical modelling of oncolytic virotherapy (opens in a new tab)

  4. Pharmacological Improvement of Oncolytic Virotherapy

    Oncolytic viruses (OV) are an emerging class of anticancer bio-therapeutics that induce antitumor immunity through selective replication in cancer cells. However, the efficacy of OVs as single agents remains limited. We postulate that resistance to oncolytic virotherapy results in part from the …

    ottawa-retro Repository record for Pharmacological Improvement of Oncolytic Virotherapy (opens in a new tab)

  5. Targeting Tumour Vasculature with Oncolytic Viruses

    Oncolytic viruses (OVs) have been engineered or selected for cancer cell-specific infection; however, we have found that following intravenous administration of vesicular stomatitis virus (VSV), tumour cell killing rapidly extends far beyond the initial sites of infection. This Bystander Effect is …

    ottawa-retro Repository record for Targeting Tumour Vasculature with Oncolytic Viruses (opens in a new tab)

  6. Potentiating the Oncolytic Efficacy of Poxviruses

    … wild-type poxviruses have emerged as potential oncolytic viruses (OVs), including orf virus (OrfV), and vaccinia virus (VV). Oncolytic VVs have been modified to include attenuating mutations that enhance their tumour selective nature, but these mutations also reduce overall viral fitness in …

    ottawa-retro Repository record for Potentiating the Oncolytic Efficacy of Poxviruses (opens in a new tab)

  7. Optimizing oncolytic adenoviruses for treatment of cholangiocarcinoma

    Oncolytic adenoviruses offer a promising new treatment for cancers, especially those which respond poorly to current therapies such as cholangiocarcinoma. However, for clinical use, high selectivity to cancers is required. Thus, I constructed two EGFP-reporter gene expressing viruses, …

    birmingham Download PDF for Optimizing oncolytic adenoviruses for treatment of cholangiocarcinoma (opens in a new tab)

  8. A Flexible Simulator for Oncolytic Viral Therapy

    Developments in recombinant DNA technology have given researchers the ability to modify viruses so that they are highly selective towards cancer cells. Engineered viruses have successfully treated cancer in human trials. In an effort to better understand viral population dynamics in a temporal …

    umn Repository record for A Flexible Simulator for Oncolytic Viral Therapy (opens in a new tab)

  9. Novel Oncolytic Herpesviruses for Breast Cancer Treatment

    Oncolytic herpes simplex virus type-1 (HSV-1) has shown great potential as an effective agent for cancer therapy ¨C oncolytic virotherapy. To enhance oncolytic capabilities of previously reported agents, new oncolytic and fusogenic HSV-1 OncSyn and OncdSyn viruses were constructed based on wild …

    lsu-thes Repository record for Novel Oncolytic Herpesviruses for Breast Cancer Treatment (opens in a new tab)

  10. Enhancing Oncolytic Virotherapy Using Functional Genomic Screening

    The treatment of cancer patients with oncolytic vaccinia virotherapy has yielded encouraging results in early phase clinical trials, but there are yet unexplored opportunities for improving this therapy that could lead to even better outcomes for patients. To this end, we harnessed the power of …

    ottawa-retro Repository record for Enhancing Oncolytic Virotherapy Using Functional Genomic Screening (opens in a new tab)

  11. Aptamers as Enhancers of Oncolytic Virus Therapy

    Oncolytic viruses promise to significantly improve current cancer treatments through their tumour-selective replication and multimodal attack against cancer cells. However, one of the biggest setbacks for oncolytic virus therapies is the intravenous delivery of the virus, as it can be cleared by …

    ottawa-retro Repository record for Aptamers as Enhancers of Oncolytic Virus Therapy (opens in a new tab)

  12. Assessing the oncolytic potential of reovirus reassortants

    Type 3 Dearing (T3D) reovirus is an oncolytic virus able to lyse a majority of tumor types. The major drawback is that ∼20% of tumor types are resistant to lysis by T3D and therefore there is a need to improve the oncolytic ability of reovirus to include resistant tumors. When designing an …

    ottawa-retro Repository record for Assessing the oncolytic potential of reovirus reassortants (opens in a new tab)

  13. Harnessing Oncolytic Virus-mediated Anti-tumour Immunity

    Treatment of permissive tumours with the oncolytic virus (OV) VSV-Δ51 leads to a robust anti-tumour T cell response, which contributes to efficacy; however, many tumours are not permissive to in vivo treatment with VSV-Δ51. In an attempt to channel the immune stimulatory properties of VSV-Δ51 and …

    ottawa-retro Repository record for Harnessing Oncolytic Virus-mediated Anti-tumour Immunity (opens in a new tab)

  14. Breast Cancer Immunotherapy Using Magnetised Oncolytic Virus

    Abstract Background: Oncolytic viruses (OV) are encouraging new immunotherapies for cancer. OVs, replicate in cancer cells inducing immunogenic cell death (ICD) and activating antitumour immunity. To date, clinical use has focused on intratumoural delivery due to concerns over inadequate tumour …

    whiterose Download PDF for Breast Cancer Immunotherapy Using Magnetised Oncolytic Virus (opens in a new tab)

  15. Characterization of Oncolytic Bovine Herpesvirus Type 1

    Oncolytic viruses (OV) are a promising alternative cancer therapy due to their specificity and lack of debilitating side effects, such as those which typically accompany conventional therapeutics such as chemotherapy and radiation. Bovine herpesvirus type 1 (BHV-1) is an alphaherpesvirus with the …

    mcmaster Repository record for Characterization of Oncolytic Bovine Herpesvirus Type 1 (opens in a new tab)

  16. Enhancement of oncolytic herpes simplex type 1 virotherapy

    … excellent safety data, antitumor efficacy of the oncolytic herpes simplex virus type 1 (oHSV-1) in glioblastoma (GBM) patients is not satisfactory. A major enhancement of the oncolytic activity of the oHSV-1 is necessary to eradicate the GBM in clinics. To enhance the efficacy and tumour …

    ubc Repository record for Enhancement of oncolytic herpes simplex type 1 virotherapy (opens in a new tab) Download PDF for Enhancement of oncolytic herpes simplex type 1 virotherapy (opens in a new tab)

  17. Recombinant negative-strand RNA viruses for oncolytic therapy

    the-open-u

  18. Development of sindbis virus as an oncolytic agent

    … viruses currently in development for use as oncolytic agents.</p> <p>Sindbis virus is a member of the Alphavirus family that has shown promising anti-cancer activity in pre-clinical models. A concern for the clinical use of Sindbis virus as an anticancer agent is its pathology in humans, …

    oxford Repository record for Development of sindbis virus as an oncolytic agent (opens in a new tab)

  19. Engineering Large DNA Viruses for Enhanced Oncolytic Virotherapy

    Oncolytic viruses (OVs) offer a promising approach to cancer immunotherapy, but challenges in safety, efficacy, and engineering complex platforms remain. This thesis addresses these hurdles with novel tools and strategies. We designed an array of chemically inducible systems, controlled by …

    ottawa-retro Repository record for Engineering Large DNA Viruses for Enhanced Oncolytic Virotherapy (opens in a new tab)

  20. Bio-Engineering Vaccinia Viruses for Increased Oncolytic Potential

    … elements that together create an optimal “oncolytic engine”. Using a transposon insertion strategy and deep sequencing of viral populations we systematically examined Vaccinia genes that do or do not play a role in the therapeutic activity of the virus. Our studies allowed us to identify a …

    ottawa-retro Repository record for Bio-Engineering Vaccinia Viruses for Increased Oncolytic Potential (opens in a new tab)

Page 1 of 20